Recombinant human granulocyte colony stimulating factor injection

Description

Granulocytopenia resulting from chemotherapy
For cancer patients takingbone marrow suppression drugs, especially after the treatment with some strong bone marrow deprivation chemical drugs, the injection of this drug can prevent granulocytopenia, lighten the degree of granulocytopenia, shorten duration of granulocytopenia and speed up the recovery of the granulocytes, consequently reducing the risk of combined infection.

*5ug/0.5ml,**0ug/0.5m, **0ug/ml

[Storage]Store at **8℃

[Package]Pre-filled syringe or vial, 1 syringe or 1 vial/box

[Shelf Life]*4 months.